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Introduction
Decades of physiological research in sport have resulted in gaining relatively considerable 
knowledge of the functional response of the human 
body to physical activities. Regular exercise brings 
about a variety of metabolic and morphological 
changes including mitochondrial biogenesis, muscle 
fiber-type transformation, substrate metabolism, and 
improvements in the circulatory system [1]. Although 
the physiological reactions in the human body 
Abstract
Angiotensin converting enzyme gene (ACE) is the most 
frequently investigated genetic marker in the context of genetic 
conditioning of athletic predispositions. However, the knowledge 
of ACE’s potential modifying effect on changes in selected body 
traits achieved through a training programme is still limited. 
Therefore, we have decided to check whether selected body 
mass, body composition variables, oxygen uptake parameters as 
well as strength/speed parameters observed in physically active 
participants will be modulated by the ACE I/D polymorphism. 
The genotype distribution was examined in a group of 201 
young healthy women measured for chosen traits before and 
after the completion of a 12-week moderate-intensive aerobic 
training programme. Our results revealed the significant 
genotype × training interactions for VEmax and power of 
countermovement jump, whereas training improvements 
were demonstrated for almost all parameters. In addition, 
main effects of the ACE I/D genotype on TGL, HDL, glucose 
and 10 m run were observed. A significant increase in VEmax 
was demonstrated for II and DD genotypes, but not for ID 
heterozygotes. The greatest gain in power of countermovement 
jump was observed in II homozygotes, although DD and ID 
were associated with a significant increase as well. Our study 
indicated that the polymorphism was associated with changes 
in VEmax and power of countermovement jump in response to 
a 12-week aerobic training programme in Caucasian women. 
However, more experimental studies are needed to establish the 
ACE gene × physical activity interactions.
KEYWORDS: ACE I/D polymorphism, gene × physical activity 
interaction, training programme.
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following regular exercise are quite well described, the 
genetic background of the reactions still remains mostly 
unknown. An understanding of the genetic determinants 
will allow us to clarify the criteria of physical activities 
for individuals [2]. In the future, this knowledge 
should help to identify individuals who are expected to 
respond well or poorly to exercise, thus making training 
programs much more efficient (possibility of accurate 
prediction of the training results including weight loss 
and improve health) and safer (early prevention of 
possible overload, injuries, cardiomyopathies, sudden 
death etc.) [3, 4]. It might be even used to predict the 
best sport-specific genetic background [5].
The most frequently investigated genetic markers in 
the context of athletic predisposition is the angiotensin 
converting enzyme gene (ACE) I/D polymorphism. 
Variants in this genes have been reported to be associated 
with elite athletic performance and with normal, 
quantitative physical performance traits in the general, 
even if this association has been often conflicting [6]. The 
product of ACE is one of the key components of the renin 
angiotensin system (RAS) which catalyses production 
of angiotensin II (ANG II) from angiotensin I (ANG 
I), resultantly increasing blood pressure. Furthermore, 
the enzyme is the essential part of the kallikrein-kinin 
system (KKS) where it degrades kinins into inactive 
fragments, thus reducing blood pressure. Moreover, the 
ACE is expressed in skeletal muscles, where it influences 
its function and biomechanical properties [7, 8, 9]. The 
human ACE gene is located on chromosome 17 in position 
17q23.3 with a restriction fragment length polymorphism 
consisting of the presence (insertion, I) or absence 
(deletion, D) of a 287 base pair Alu repeat sequence in 
intron 16 [10]. In this case, three ACE genotypes include 
DD, II homozygotes, and ID heterozygotes [11]. Studies 
concerning links between the ACE genotype and athlete 
status have shown that the I allele is associated with lower 
ACE activity in both serum and tissue and improved 
performance in endurance sports [12]. Meanwhile, the D 
allele is associated with greater circulating and the ACE 
activity and causes an enhanced performance at sports 
requiring sprinting or short bursts of power [13, 14].
Considering the above-mentioned facts, we studied 
the possible impact of ACE I/D variant on the aerobic 
and anaerobic performance as well as body and mass 
composition measurements in physically active 
participants. Therefore, we examined the allele and 
genotype distribution in young Polish women measured 
for selected traits before and after the completion of a 
12-week training programme to see whether there was 
an interaction between genotype and training.
Materials and Methods
Ethics Statement
All the procedures followed in the study were approved 
by the Ethics Committee of the Regional Medical 
Chamber in Szczecin (Approval number 09/KB/
IV/2011) and were conducted ethically according 
to the principles of the World Medical Association 
Declaration of Helsinki and ethical standards in 
sport and exercise science research. Furthermore, the 
experimental procedures were conducted in accordance 
with the set of guiding principles for reporting the 
results of genetic association studies defined by the 
Strengthening the Reporting of Genetic Association 
studies statement (STREGA). All participants filled in a 
consent form and a written information sheet concerning 
the study, providing all pertinent information (purpose, 
procedures, risks, and benefits of participation). 
Participants 
201 Polish Caucasian women aged 19-24 years (21 ± 1) 
years met the inclusion criteria and were included in the 
study. None of these individuals had engaged in regular 
physical activity in the previous 6 months. They had 
no history of any metabolic or cardiovascular diseases. 
Participants were nonsmokers and refrained from 
taking any medications or supplements known to affect 
metabolism. Prior to the start of the training phase, 
participants were asked to maintain a balanced diet of 
approximately 2000 kilocalories a day.
Physical exercise training protocol 
The training stage was preceded by a week-long 
familiarization stage, during which the examined women 
exercised 3 times a week for 30 minutes, at an intensity of 
about 50% of their maximum heart rate (HRmax). After 
the week-long familiarization stage, the proper training 
started. Each training unit consisted of a warm-up routine 
(10 minutes), the main aerobic routine (43 minutes), and 
a cool-down phase (stretching and breathing exercise for 
7 minutes). The main aerobic routine was a combination 
of two alternating styles – low and high impact. The low 
impact style comprised of movements with at least one 
foot on the floor at all times, whereas the high impact style 
included running, hopping, and jumping with a variety of 
flight phases. Music of variable rhythm intensity (tempo) 
was incorporated into both styles. A 12-week program 
of low-high impact aerobics was divided as follows: 
(i) 3 weeks (9 training units), 60 minutes each, at about 
50–60% of HRmax, 135–140 BPM; (ii) 3 weeks 
(9 training units), 60 minutes each, at 60–70% of HRmax, 
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140–152 BPM; (iii) 3 weeks (9 training units), 60 minutes 
with the intensity of 65%−75% of HRmax, 145–158 BPM; 
and (iv) 3 weeks (9 training units), 60 minutes with an 
intensity of 65%−80% of HRmax, 145–160 BPM. All 36 
training units were administered and supervised by the 
same instructor.
Body Composition Measurements 
All participants were measured for selected body 
mass and body composition variables before and after 
the completion of a 12-week training period. Body 
mass and body composition were assessed with the 
bioimpedance method (body’s inherent resistance 
to an electrical current) using a “Tanita TBF 300M” 
electronic scale (Horton Health Initiatives, USA). The 
device was plugged in and calibrated to account for the 
weight of clothing (0.2 kg). Afterwards, data regarding 
a participant’s age, body height, and sex were entered. 
Then, the subjects stood on the scale with their bare 
feet on the marked places. The device analyzes body 
composition based on the differences of the ability to 
conduct electrical current by body tissues (different 
resistance) due to different water content. Body mass 
and body composition measurements taken with the use 
of the “Tanita” electronic scale are as follows: total body 
mass (kg), fat free mass (FFM, kg), fat mass (kg), fat mass 
percentage (FM, %), body mass index (BMI, kg/m2), 
tissue impedance (Ohm), total body water (TBW, kg), 
and basal metabolic rate (BMR, kJ or kcal).
 
Aerobic capacity test (VO2max) 
Participants performed a continuous graded exercise test 
on an electronically braked cycle ergometer (Oxycon 
Pro, Erich JAEGER GmbH, Hoechberg, Germany) to 
determine their VO2max, HRmax, VEmax, Pmax before 
and after the completion of a 12-week training period. 
The test began with 5 minutes of continuous pedaling, 
with a frequency of 60 revolutions per minute (RPM) 
and a relative load of 1.2 W·kg–1. After this phase, the 
workload was systematically increased by 15 watts every 
minute until exhaustion. The effort was interrupted when 
pedalling frequency declined by 10%, that is, when the 
pedalling frequency fell below 54 RPM. The highest value 
of the oxygen uptake, heart rate, minute ventilation and 
power output maintained for 15 seconds was considered 
to be the VO2max, HRmax, VEmax, Pmax. The anaerobic 
threshold values were obtained using the V-slope method.
The Wingate anaerobic test 
A 30-s Wingate test on a cycle ergometer (Monark 
Ergomedic 894 E, Monark, Sweden) was used to assess 
the peak power and total work before and after the 
completion of a 12-week training period. A relative 
load corresponding to 7.5% of the subject’s body 
mass was applied [15]. Before performing the test, the 
participants completed a 10-min warm-up, including 
pedaling at a frequency of 60 rotations per minute 
(RPM), with a relative load of 1.2 W∙kg–1 and three 
rapid accelerations between the 7th and 10th minute 
[16, 17]. After the warm-up, the subjects performed five 
minutes of stretching and relaxing exercises and then 
started the test. 
Biochemical and Hematological Analyses
Fasting blood samples were obtained in the 
morning from the elbow vein. Blood samples from 
each participant were collected in two tubes. For 
biochemical analyses, a 4.9 mL S-Monovette tube with 
ethylenediaminetetraacetic acid (K 3 EDTA; 1.6 mg 
EDTA/mL blood) and separating gel (SARSTEDT AG 
& Co., Nümbrecht, Germany) were used. For complete 
blood count, a 2.6 mL S-Monovette tube with K 3 
EDTA (1.6 mg EDTA/mL blood) (SARSTEDT AG & 
Co., Nümbrecht, Germany) was used. Blood samples 
for biochemical analyses were centrifuged 300 × g for 
15 minutes at room temperature in order to receive 
blood plasma. Biochemical and hematological analyses 
were performed before the start of the aerobic fitness 
training programme and repeated at the 12th week of 
this training programme (after the 36th training unit). 
The analyses were performed immediately after the 
blood collection. Complete blood count, including white 
blood cells (WBC), red blood cells (RBC), haemoglobin 
(HGB), haematocrit (HTC), mean corpuscular volume 
(MCV), mean corpuscular haemoglobin (MCH), mean 
corpuscular haemoglobin concentration (MCHC), and 
total platelet level (PLT) were obtained using Sysmex 
K-4500 Haematology Analyzer (TOA SYSMEX, Kobe, 
Japan). All biochemical analyses were conducted using 
the Random Access Automatic Biochemical Analyzer 
for Clinical Chemistry and Turbidimetry A15 (BIO- 
SYSTEMS S.A., Barcelona, Spain). Blood plasma 
was used to determine lipid profile: triglycerides (Tg), 
cholesterol (Chol), high-density lipoprotein (HDL) and 
low-density lipoprotein (LDL) concentrations. Plasma 
Tg and Chol concentrations were determined using 
diagnostic colorimetric enzymatic method according to 
the manufacturer’s protocol (BioMaxima S.A., Lublin, 
Poland). Manufacturer’s declared intra-assay coefficients 
of variation (CV) of the method were < 2.5% and < 1.5% 
for the Tg and Chol determinations, respectively. HDL 
plasma concentration was determined using human 
TRENDS IN SPORT SCIENCES206 December 2016
CIĘSZCZYK, JASTRZĘBSKI, ZARĘBSKA, SAWCZYN, DROBNIK-KOZAKIEWICZ, LEOŃSKA-DUNIEC, ŻMIJEWSKI,
MURAWSKA-CIAŁOWICZ, PETR, CONTRÒ, PROIA, ZAREMBA, SZUMIŁO
anti-ß-lipoprotein antibody and colorimetric enzymatic 
method according to the manufacturer’s protocol 
(BioMaxima S.A., Lublin, Poland). The manufacturer’s 
declared intra-assay CV of the method was < 1.5%. 
Plasma concentrations of LDL were determined using 
a direct method according to the manufacturer’s 
protocol (PZ Cormay S.A., Lomianki, Poland). The 
manufacturer’s declared intra-assay CV of the method 
was 4.97%. All analysis procedures were verified with 
the use of multiparameteric control serum (BIOLABO 
S.A.S, Maizy, France), as well as control serum of 
normal level (BioNormL) and high level (BioPathL) 
lipid profiles (BioMaxima S.A., Lublin, Poland).
Genetic Analyses
Genomic DNA was extracted from the buccal cells 
using a GenElute Mammalian Genomic DNA Miniprep 
Kit (Sigma, Germany), according to the manufacturer’s 
protocol. PCR amplification of the polymorphic region 
of the ACE gene containing either the insertion (I) 
or deletion (D) fragment was performed. One pair of 
primers (forward: CTG GAG ACC ACT CCC ATC 
CTT TCT and reverse: GAT GTG GCC ATC ACA TTC 
GTC AGA) was used to determine the ACE genotype, 
yielding amplification products of approximately 490 
bp (for the I allele) and 190 bp (for the D allele), as 
described by Rigat et al. [12]. PCR mixture and thermal- 
-time profile were coequal as earlier described [18]. 
The amplified DNA fragments were visualized by using 
1.5% agarose gels stained with ethidium bromide. 
Statistical Analysis
Allele frequencies were determined by gene counting. 
A chi-square test was used to test the Hardy-Weinberg 
equilibrium. Normality was evaluated by Kolmogorov-
Smirnov test as well as the visual inspection of the 
histograms. As there were between-subject (ACE 
genotype) and within-subject factors (training status), the 
2 × 2 mixed-design ANOVA with repeated measures was 
used to test the influence of the ACE I/D polymorphism on 
training response. The post hoc Fisher’s least significant 
difference (LSD) test was used. The level of statistical 
significance was set at p < 0.05.
Results
The ACE I/D genotype frequencies conformed to Hardy-
Weinberg equilibrium (Chi-square 1.96, p = 0.162). The 
training adaptation of body mass, body composition 
variables, oxygen uptake parameters as well as strength/
speed parameters with respect to I/D ACE polymorphism 
was evaluated with two-way factorial ANOVA with 
repeated measures. We found the genotype × training 
Table 1. ACE genotypes and body mass and body composition variables before and after training (two-way mixed ANOVA)
Parameter
II (n = 42) ID (n = 65) DD (n = 40)












Body mass (kg) 61.3±7.9 60.3±7.5 59.7±7.2 59.2±7.2 62.0±7.4 61.2±7.7 p=0.334 p<0.0001* 0.274
BMI 
(kg × m-2) 21.8±2.6 21.4±2.5 21.5±2.0 31.4±2.1 22.0±2.8 21.8±2.7 p=0.638 p<0.0001* 0.203
BMR (kJ) 6087±333 6020±298 6018±312 5991±313 6111±307 6082±309 p=0.320 p<0.0001* 0.194
FM (%) 23.9±5.6 22.4±5.0 23.9±5.2 22.6±5.7 24.8±5.6 23.1±6.4 p=0.762 p<0.0001* 0.739
FM (kg) 14.9±5.4 14.0±5.1 14.6±4.8 13.7±5.0 15.7±5.1 14.5±5.5 p=0.621 p<0.0001* 0.708
FFM (kg) 46.2±2.8 46.6±3.1 45.0±3.0 45.5±3.0 46.3±3.3 46.8±3.3 p=0.057 p<0.0001* 0.906
TBW (kg) 33.8±2.1 34.1±2.3 33.0±2.8 33.4±2.3 33.9±2.5 34.3±2.5 p=0.088 0.005* 0.963
Chol (mg/dl) 166.8±24.4 166.6±24.6 171.0±25.0 169.3±27.3 171.4±25.7 172.5±30.2 p=0.605 0.902 0.799
TGL (mg/dl) 75.0±22.4 76.8±22.8 86.1±32.0 88.9±44.2 73.1±25.8 79.6±24.0 p=0.041* 0.178 0.803
HDL (mg/dl) 63.2±14.9 62.2±11.3 62.4±12.0 57.9±12.7 69.4±11.6 64.5±12.5 p=0.013* 0.0003* 0.191
LDL (mg/dl) 88.4±20.6 89.4±22.1 91.0±20.6 93.4±22.8 87.2±21.6 91.9±25.7 p=0.658 0.079 0.648
Glucose (mg/dl) 78.7±9.0 73.7±10.1 75.0±8.9 73.4±9.1 79.5±12.0 79.0±11.7 0.013* 0.009* 0.130
Mean ± standard deviation; p – values for main effects (genotype and training) and genotype × training interactions; BMI – body mass 
index; BMR – basal metabolic rate; FM – fat mass percentage; FFM – fat free mass; TBW – total body water; Chol – cholesterol; TGL – 
triglycerides; HDL – high-density lipoprotein; LDL – low-density lipoprotein
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Table 2. ACE genotypes and maximal oxygen uptake test parameters before and after training (two-way mixed ANOVA)
Parameter
II (n = 42) ID (n = 65) DD (n = 40)













(ml/kg/min) 34.18±5.1 38.30±6.0 33.37±5.2 36.68±6.3 33.34±4.6 36.03±5.1 0.311 p<0.0001* 0.412
VO2/AT 




0.73±0.10 0.74±0.08 0.75±0.08 0.75±0.07 0.72±0.09 0.75±0.08 0.393 p=0.108 0.130
HRmax 
(beats/min) 184.57±8.4 186.88±7.9 187.78±10.5 186.91±8.9 186.8±7.9 185.68±8.0 0.553 p=0.881 0.088
HR/AT
(beats/min) 162.29±11.8 165.10±9.8 165.40±13.6 167.34±11.0 162.43±13.5 164.03±10.3 0.254 0.021 0.869
HRAT/HRmax 
(%) 0.88±0.05 0.88±0.04 0.88±0.05 0.90±0.04 0.87±0.06 0.88±0.05 0.352 0.010 0.612
VEmax 
(l/min) 71.43±18.0 83.36±19.6 70.27±18.1 73.92±18.1 71.31±15.5 78.05±15.5 0.250 p<0.0001* 0.017*
VE/AT 
(l/min) 38.52±8.2 46.42±11.0 37.93±8.9 42.22±11.6 38.30±9.2 43.22±7.7 0.341 p<0.0001* 0.178
VEAT/VEmax
 (%) 0.56±0.1 0.57±0.1 0.55±0.1 0.58±0.1 0.55±0.1 0.57±0.1 0.841 0.045 0.907
Values of the parameters of both groups before and after training are means (± SD); *p – value 0.05; VO2max – maximum oxygen uptake; 
VO2/AT – oxygen uptake at anaerobic threshold; VO2AT/VO2max – percentage of VO2max at anaerobic threshold; HRmax – maximum heart 
rate; HR/AT – heart rate at anaerobic threshold; HRAT/HRmax – percentage of HRmax at anaerobic threshold; VEmax – maximum minute 
ventilation; VE/AT – minute ventilation at anaerobic threshold; VEAT/VEmax – percentage of VEmax at anaerobic threshold
Table 3. ACE genotypes and Wingate test parameters before and after training (two-way mixed ANOVA)
Parameter
II (n = 42) ID (n = 65) DD (n = 40)












Pmax (W/kg) 8.04±0.6 8.49±0.8 7.74±1.0 8.14±0.9 7.80±0.7 8.11±0.9 0.097 p<0.0001* 0.559
Tr (s) 6.41±2.1 5.60±2.2 6.85±2.1 5.77±2.0 6.38±2.1 5.30±2.1 0.418 p<0.0001* 0.754
Tm (s) 3.58±1.1 4.07±1.74 3.74±1.5 4.44±1.7 3.63±1.09 4.11±1.8 0.522 p<0.0001* 0.735
Values of the parameters of both groups before and after training are means (± SD); *p – value 0.05; Pmax – maximal power; Tr – time to 
reaching Pmax; Tm – time of maintaining Pmax
Table 4. ACE genotypes and speed parameters before and after training (two-way mixed ANOVA)
Parameter
II (n = 42) ID (n = 65) DD (n = 40)












Run 5 m 1.28±0.07 1.25±0.07 1.29±0.07 1.25±0.08 1.30±0.07 1.27±0.06 0.340 p<0.0001* 0.684
Run 10 m 2.21±0.11 2.14±0.10 2.21±0.14 2.15±0.12 2.25±0.09 2.21±0.10 0.031* p<0.0001* 0.297
Run 30 m 5.26±0.28 5.22±0.34 5.29±0.32 5.25±0.34 5.40±0.23 5.31±0.23 0.243 p<0.0001* 0.642
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interactions for VEmax (F(2, 144) = 4.17, p = 0.017) (Table 
2) and power of countermovement jump (F2, 144) = 3.47, 
p = 0.034) (Table 5), whereas training improvements were 
demonstrated for almost all parameters, except blood 
lipids (Chol, TGL, LDL), VO2AT/VO2max, HRmax 
(Table 1-5). In addition, main effect of ACE I/D genotype 
on TGL, HDL, glucose and 10 m run were observed (Table 
1, 4). A significant increase in VEmax was demonstrated 
for II (71.43 ± 18.0 vs 83.36 ± 19.6, p = 0.0002) and DD 
(71.31 ± 15.5 vs 78.05 ± 15.5, p = 0.039) genotypes, but 
not for ID heterozygotes (70.27 ± 18.1 vs 73.92 ± 18, 
p = 0.323) (Table 2). The greatest gain in power of 
countermovement jump was observed in II homozygotes 
(37.94 ± 4.2 vs 41.27 ± 4.8, p = 0.0002) although DD 
and ID were associated with a significant increase as well 
(36.92 ± 3.5 vs 39.92 ± 3.8 and 38.22 ± 4.2 vs 39.87 ± 4.4, 
respectively) (Table 5).
Discussion
The main objective of the proposed research was to 
determine the impact of a polymorphism of a selected 
gene on the characteristics and extent of the body’s 
adaptive response to training. To detect a correlation 
between the ACE I/D genetic polymorphism and 
selected body composition measurements in participants 
undergoing training program we examined the genotype 
distribution of the ACE I/D allele in a group of 201 
young Polish women measured for selected body mass, 
body composition variables, oxygen uptake parameters 
as well as strength/speed parameters before and after the 
completion of a 12-week training period. An important 
finding of this study was the significant genotype 
× training interactions for VEmax and power of 
countermovement jump, whereas training improvements 
were demonstrated for almost all parameters, except 
blood lipids (Chol, TGL, LDL), VO2AT/VO2max, and 
HRmax. In addition, main effects of ACE I/D genotype 
on TGL, HDL, glucose and 10 m run were observed. A 
significant increase in VEmax was demonstrated for II 
and DD genotypes, but not for ID heterozygotes. The 
greatest gain in power of countermovement jump was 
observed in II homozygotes, although DD and ID were 
associated with a significant increase as well.
The ACE gene is most often studied in the context of 
genetic determinants of a predisposition to sports, as the 
product of this gene (angiotensin converting enzyme) is 
considered to be a key element of the renin-angiotensin 
system (RAS) responsible for regulating blood pressure, 
one of the main factors determining the efficiency of the 
body [19]. Montgomery et al. [20] observed the increased 
effectiveness of implemented training (expressed in 
longer duration of exercise) in the British Army recruits 
with ACE II genotype, compared to recruits with DD 
genotype. The possibility of continuing exercise (arm 
bending with extra load – 15 kg medicine ball) were up 
to eleven times higher in men with genotype II compared 
to those with the DD genotype [20]. In another study, 
also on army recruits, Williams et al. [21] showed that 
the presence of ACE I allele may effectively enhance the 
efficiency of skeletal muscle after an 11-week aerobic 
training programme. Further research on a potential 
link between ACE gene II genotype and increased 
response parameters after training focused on patients 
suffering from cardiovascular and respiratory diseases. 
Defoor et al. [22] showed that the aerobic fitness of 
the body in response to training carried out in patients 
with coronary heart disease increased to a much greater 
extent in subjects with genotype II than in individuals 
having at least one D allele [22]. A similar conclusion 
was reached by Gosker et al. [23] in a study of people 
suffering from chronic lung disease. One of the few 
works of this type, based on research with athletes, 
Table 5. ACE genotypes and jump parameters before and after training (two-way mixed ANOVA)
Parameter
II (n = 42) ID (n = 65) DD (n = 40)












Jump with hands 
on hips (cm) 23.66±4.3 25.21±3.8 23.80±3.9 24.94±3.7 23.53±3.6 24.70±3.7 0.908 p<0.0001* 0.783
Power of jump – 
hands 
on hips (W)




27.99±5.0 30.82±4.6 27.31±5.9 29.75±4.0 27.28±4.9 29.77±4.6 0.567 p<0.0001* 0.880
Power of counter 
movement 
jump (W)
37.94±4.2 41.27±4.8 38.22±4.2 39.87±4.4 36.92±3.5 39.92±3.8 0.374 p<0.0001* 0.034*
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was Cam et al. (2007). In a study of 55 Turkish female 
athletes, after aerobic training, women with gene type II 
had significantly better results during the 30-minute run 
and displayed more favorable changes in physiological 
parameters than athletes under the same training regime 
but with the DD genotype [24]. The necessity of further 
research is not only connected with the hitherto very 
limited scope (only a few papers published) but also 
with ambiguous results. For example, Rankinen et 
al. [25] showed that much better gains in VO2max in 
response to training were observed in individuals with 
DD homozygotes, not in those with II homozygotes, as 
indicated by the aforementioned papers [25].
One of the first papers to analyze the correlation between 
the insertion-deletion polymorphisms of the ACE gene 
and changes in the power/strength parameters of muscle 
contraction was Folland et al. [26]. After a 9-week long 
training schedule they observed higher increases in 
muscle strength in individuals with the D allele. Further 
studies included, for example, Giaccaglia et al. [27] who 
examined responses to bodybuilding training among the 
elderly (18 months long). In both groups, among men 
and women, greater increases in knee flexor muscle 
strength, were obtained by individuals with DD genotype 
compared with subjects with genotype II [27]. Cam et al. 
[24] (2007) examined the relationship between the I/D 
polymorphism of the ACE gene and speed training. The 
study covered a group of women among which a more 
favorable response (shown in parameters desirable in 
sprint) was observed among participants with the DD 
genotype [24] (Cam et al. 2007). Pescatello et al. [28] 
examined the effect of the I/D polymorphism of the 
ACE gene on dynamic strength/power gains in the upper 
limb in non-sporting and sporting men and women. The 
highest training-induced increments were observed in 
trained individuals possessing at least one D allele [28].
The present study was not without limitations. The 
obtained results of the genetic associations studies need 
to be interpreted with caution as they can be influenced 
by many factors. The failure to detect gene x physical 
activity interaction effects in our study may reflect the 
influence of population-specific characteristics such as 
high overall physical activity levels and relatively low 
weight in the studied population, a small sample size, 
or the effect of age. In addition, athletic performance 
is a polygenic trait; over 79 polymorphisms have been 
associated with elite athlete status. The genetic marker 
analysed independently is likely to make a limited 
contribution to an “elite phenotype”: it seems more 
likely that such status depends on the simultaneous 
presence of multiple such variants [3].
In summary, we described the significant genotype 
× training interactions for VEmax and power of 
countermovement jump, whereas training improvements 
were demonstrated for almost all parameters. In 
addition, main effects of ACE I/D genotype on TGL, 
HDL, glucose and 10 m run were observed. However, 
more experimental studies are needed to establish the 
ACE gene × physical activity interactions.
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